Head-to-head · Cost-Efficiency Index
Sprout Health vs Brightmeds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Sprout Health
Price-conscious shoppers who want a quick online intake and don't mind a subscription that bills every four weeks.
Visit Sprout HealthBrightmeds
Shoppers who want a low flat price at every dose on compounded semaglutide or tirzepatide, with the option to save more on a three-month pack.
Visit BrightmedsThe verdict
Brightmeds takes it, leading the Cost-Efficiency Index 82 to 80. Brightmeds sells compounded semaglutide at $129 a month and tirzepatide at $149 month to month, the same at every dose, or $99 and $119 a month if you prepay a three-month pack. Sprout Health still earns a B− — Price-conscious shoppers who want a quick online intake and don't mind a subscription that bills every four weeks.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Brightmeds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Sprout Health | Brightmeds |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 82/100 |
| Semaglutide / mo | $149 per 4 weeks$99/mo on a prepaid 12-month plan | $129/moCompounded, month to month, same price at every dose; $99/mo on a 3-month pack billed $297 |
| Tirzepatide / mo | $199 per 4 weeks$149/mo on a prepaid 12-month plan | $149/moCompounded, month to month, same price at every dose; $119/mo on a 3-month pack billed $357 |
| Semaglutide / yr (modeled) | $1,93713 charges | $1,548 |
| Tirzepatide / yr (modeled) | $2,58713 charges | $1,788 |
| Coverage | 44 states (not AL, AR, CA, LA, MS or ND) | 38 states + DC |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #24 | #28 |
Sprout Health
80/100Where the value is
- Prices are on the homepage before you start: $149 or $199 every four weeks, or $1,188 and $1,788 for a prepaid year
- A licensed clinician reviews your intake, and most prescriptions reach the pharmacy within two business days
- Sprout names its dispensing pharmacies, Foothills Pharmacy and Promise Pharmacy, in its terms
The tradeoffs
- Billing runs every four weeks, so the monthly plan is 13 charges a year, about $1,937 on semaglutide and $2,587 on tirzepatide
- Cancel after a provider has reviewed your case and you lose a $50 review fee; once the prescription reaches the pharmacy, nothing is refunded
Regulatory note: the FDA issued a warning letter to Sprout Health Partners LLC dba Sprout Health in September 2025. We still list and link to Sprout Health; you should know the letter is on the public record before you decide.
Brightmeds
82/100Where the value is
- Month-to-month prices of $129 for semaglutide and $149 for tirzepatide are on the pricing page, and the price stays the same as your dose goes up
- A three-month pack lowers that to $99 and $119 a month, and you can choose month to month instead
- Medication, clinician visits, dose adjustments and shipping are included, with no membership, consultation or lab fee
The tradeoffs
- The advertised GLP-1 prices apply only in 38 states and D.C.; if you are already on a GLP-1 or transferring a prescription, you must contact support for pricing
- Its terms say fees are otherwise non-refundable, and month-to-month plans renew automatically until you cancel
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.